CENTRAL BANK STATEMENTS (2022)
The Brazilian Central Bank (“BACEN”) has throughout the past years been vigorously acting on the monitoring of compliance with the several ancillary obligations under its supervision (late transmission and/or incongruences on the information transmitted may subject Brazilian companies to the application of penalties), starting, when applicable, punitive administrative proceedings, as well as applying precautionary measures such as the suspension of registrations.
For such reasons the attention to the deadlines and details on information to be provided becomes even more important. Below follows details on the main ancillary obligations to be fulfilled in the calendar year of 2022.
FOREIGN DIRECT INVESTIMENT (RDE-IED)
Brazilian companies receiving foreign direct investment shall, until the date of March 31st, 2022, submit the corresponding Annual or Economic-Financial Statement (depending on its assets and net equity values) encompassing their net equity, amount of paid-in corporate capital, and equity interest held by foreign entities, pertaining to the reference date of December 31st, 2021, before the Foreign Direct Investment Modul of the Electronic Declaratory Registry (RDE-IED) of the Central Bank Information System — “Sisbacen”.
ANNUAL CENSUS OF FOREIGN INVESTIMENTS
Brazilian companies receiving foreign direct investment (regardless of the amount) and investment funds with non-resident quota holders with net equity value equal or exceeding US$100,000,000.00 (one hundred million United States Dollars) on December 31st, 2021; as well as Brazilian companies which short-term commercial debts (i.e., payable within 360 days) with foreigners exceed US$10,000,000.00 (ten million United States Dollars) shall deliver, until the date of August 15th, 2022, the corresponding Foreign Investment Annual Census Statement, encompassing information on internal accounting data and on its foreign creditors, referring to the base date of December 31st, 2021, before the Foreign Investment Census Module of Sisbacen.
